New York

UK may take several days from approval of Pfizer’s COVID-19 vaccine

The UK may be weeks ahead of the United States when it comes to approval of the COVID-19 vaccine, according to a new report.

UK regulators could turn Pfizer and BioNTech vaccines green this week, Telegraph reported.

Officials are planning to begin a formal evaluation of the vaccine, according to government sources, and the National Health Service was said to be ready to administer the vaccine by December 1.

Last week, the UK formally requested medical regulator MHRA to evaluate the suitability of the Pfizer-BioNTech vaccine.

It has ordered 40 million doses and, with regulatory approval, is expected to be 10 million doses sufficient to protect 5 million people by the end of the year.

In England and Wales, up to 30,000 volunteers are required to administer the dose.

In the United States, Pfizer sought urgent government approval of the vaccine on Friday, but said the company showed 94.5 percent efficacy in clinical trials.

The US Food and Drug Administration announced on Friday that it would meet on December 10 to discuss whether to approve the shot after a three-week review period.

Biotech company Moderna is also likely to seek a vaccine permit soon, with about 95% effectiveness, according to the company.

UK may take several days from approval of Pfizer’s COVID-19 vaccine

Source link UK may take several days from approval of Pfizer’s COVID-19 vaccine

Back to top button